Science Explorer Back to mapMap

Most cited papers in Hidradenitis Suppurativa and Treatments

Hidradenitis Suppurativa and Treatments

What are the most cited papers in Hidradenitis Suppurativa and Treatments?

The most cited paper in Hidradenitis Suppurativa and Treatments is "Secukinumab in Plaque Psoriasis — Results of Two Phase 3 Trials" (Richard G B Langley, Boni Elizabeth Elewski, Mark Lebwohl et al., 2014), with 2,004 citations. Next come "The natural history of fistulizing Crohn's disease in Olmsted County, Minnesota" (1,144) and "Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trial" (1,098).

Showing 50 of 99 papers. Every paper with more than 308 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Secukinumab in Plaque Psoriasis — Results of Two Phase 3 Trials Richard G B Langley, Boni Elizabeth Elewski, Mark Lebwohl et al. · New England Journal of Medicine Open access 9 Jul 2014 2,004
2 The natural history of fistulizing Crohn's disease in Olmsted County, Minnesota David A. Schwartz, Edward V. Loftus, William J. Tremaine et al. · Gastroenterology Open access Apr 2002 1,144
3 Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trial Julián Panés, Damián García‐Olmo, Gert Van Assche et al. · The Lancet 29 Jul 2016 1,098
4 European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa Christos C. Zouboulis, Nemesha Desai, Lennart Emtestam et al. · Journal of the European Academy of Dermatology and Venereology 30 Jan 2015 1,095
5 Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemie myocardium Kevin Mullane, Rosemary T. Kraemer, Bruce Smith · Journal of Pharmacological Methods Nov 1985 997
6 Anti–Interleukin-17 Monoclonal Antibody Ixekizumab in Chronic Plaque Psoriasis Craig L. Leonardi, Robert T. Matheson, Claus Otto Carl Zachariae et al. · New England Journal of Medicine Open access 28 Mar 2012 944
7 Brodalumab, an Anti–Interleukin-17–Receptor Antibody for Psoriasis Kim Alexander Papp, Craig L. Leonardi, Alan Menter et al. · New England Journal of Medicine 28 Mar 2012 941
8 Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial Umesh Chaudhari, Pat Romano, LD Mulcahy et al. · The Lancet Jun 2001 906
9 Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial Alan Menter, Stephen Keith Tyring, Kenneth B. Gordon et al. · Journal of the American Academy of Dermatology 3 Dec 2007 892
10 Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis Mark Lebwohl et al. · New England Journal of Medicine Open access 30 Sep 2015 826
11 Hidradenitis Suppurativa Gregor B. E. Jemec · New England Journal of Medicine 11 Jan 2012 816
12 Two Phase 3 Trials of Adalimumab for Hidradenitis Suppurativa Alexa B. Kimball et al. · New England Journal of Medicine 3 Aug 2016 804
13 Expanded Adipose-Derived Stem Cells for the Treatment of Complex Perianal Fistula Damián García‐Olmo, Dolores Herreros, Isabel Pascual et al. · Diseases of the Colon & Rectum 2009 782
14 Genomic rearrangement in NEMO impairs NF-κB activation and is a cause of incontinentia pigmenti Asma Smahi et al. · Nature May 2000 752
15 THE INFLAMMATORY LESION IN IDIOPATHIC POLYNEURITIS Arthur K. Asbury, Barry G.W. Arnason, Raymond D. Adams · Medicine May 1969 724
16 Hidradenitis suppurativa: A comprehensive review Ali Alikhan, Peter Lynch, Daniel Brian Eisen · Journal of the American Academy of Dermatology 17 Mar 2009 707
17 Activation of Toll-Like Receptor 2 in Acne Triggers Inflammatory Cytokine Responses Jenny R. Kim, Marîa Teresa Ochoa, Stephan R. Krutzik et al. · The Journal of Immunology Open access Aug 2002 660
18 Infliximab for the treatment of pyoderma gangrenosum: a randomised, double blind, placebo controlled trial Trevor N. Brooklyn, M G S Dunnill, A Shetty et al. · Gut Open access 27 Sep 2005 647
19 Prevalence and factors associated with hidradenitis suppurativa: Results from two case-control studies Jean E. Revuz, Florence Canouï‐Poitrine, P. Wolkenstein et al. · Journal of the American Academy of Dermatology 4 Aug 2008 627
20 Infliximab maintenance treatment reduces hospitalizations, surgeries, and procedures in fistulizing Crohn’s disease Gary R. Lichtenstein, Songkai Yan, Mohan V. Bala et al. · Gastroenterology Open access Apr 2005 599
21 Pyoderma gangrenosum: clinicopathologic correlation and proposed diagnostic criteria W. P. Daniel Su, Mark D.P. Davis, Roger H. Weenig et al. · International Journal of Dermatology 15 Apr 2004 582
22 Hidradenitis suppurativa Robert Sabat, Gregor B. E. Jemec, Łukasz Matusiak et al. · Nature Reviews Disease Primers Review 12 Mar 2020 574
23 Pyoderma gangrenosum: Classification and management Frank C. Powell, W. P. Daniel Su, Harold O. Perry · Journal of the American Academy of Dermatology Mar 1996 530
24 Objective scoring of hidradenitis suppurativa reflecting the role of tobacco smoking and obesity Karin Sartorius, Lennart Emtestam, Gregor B. E. Jemec et al. · British Journal of Dermatology 29 Apr 2009 528
25 Obesity and the skin: Skin physiology and skin manifestations of obesity Gil Yosipovitch, Amy DeVore, Aerlyn G. Dawn · Journal of the American Academy of Dermatology 15 May 2007 526
26 Risankizumab versus Ustekinumab for Moderate-to-Severe Plaque Psoriasis Kim Alexander Papp, Andrew Blauvelt, Michael Bukhalo et al. · New England Journal of Medicine Open access 19 Apr 2017 516
27 The prevalence of hemorrhoids in adults Stefan Riss, Friedrich Anton Weiser, Katrin Schwameis et al. · International Journal of Colorectal Disease 19 Sep 2011 512
28 Clinical response to adalimumab treatment in patients with moderate to severe psoriasis: Double-blind, randomized controlled trial and open-label extension study Kenneth B. Gordon, Richard G B Langley, Craig L. Leonardi et al. · Journal of the American Academy of Dermatology 11 Aug 2006 510
29 The prevalence of hidradenitis suppurativa and its potential precursor lesions Gregor B. E. Jemec, Michael Heidenheim, Niels Henrik Søe Nielsen · Journal of the American Academy of Dermatology Aug 1996 508
30 Lymphocytic (“microscopic”) colitis: A comparative histopathologic study with particular reference to collagenous colitis Audrey J. Lazenby, John H. Yardley, Francis M. Giardiello et al. · Human Pathology Open access 1989 501
31 Comparison of hemorrhoidal treatment modalities Helen MacRae, Robin S. McLeod · Diseases of the Colon & Rectum Jul 1995 501
32 Pyoderma gangrenosum: an updated review Eleonora Ruocco, Sonia Sangiuliano, Antonietta Gerarda Gravina et al. · Journal of the European Academy of Dermatology and Venereology 11 Mar 2009 500
33 Hidradenitis Suppurativa Ditte Marie Lindhardt Saunte, Gregor B. E. Jemec · JAMA 28 Nov 2017 495
34 Hidradenitis suppurativa Samantha R. Goldburg, Bruce E Strober, Michael J. Payette · Journal of the American Academy of Dermatology 9 Oct 2019 488
35 Autoinflammatory Disease Reloaded: A Clinical Perspective Daniel L. Kastner, Ivona A Aksentijevich, Raphaela Goldbach‐Mansky · Cell Open access Mar 2010 484
36 Development and validation of the International Hidradenitis Suppurativa Severity Score System ( IHS 4), a novel dynamic scoring system to assess HS severity Christos C. Zouboulis et al. · British Journal of Dermatology Open access 21 Jun 2017 481
37 Elevated levels of tumour necrosis factor (TNF)-α, interleukin (IL)-1β and IL-10 in hidradenitis suppurativa skin: a rationale for targeting TNF-α and IL-1β Hessel H. van der Zee, Lilian de Ruiter, D.G. van den Broecke et al. · British Journal of Dermatology 17 Feb 2011 476
38 A prospective phase III, randomized, double‐blind, placebo‐controlled study of brodalumab in patients with moderate‐to‐severe plaque psoriasis Kim Alexander Papp, Kristian Reich, Carle F. Paul et al. · British Journal of Dermatology Open access 25 Feb 2016 470
39 Community differentiation of the cutaneous microbiota in psoriasis Alexander V. Alekseyenko, Guillermo I Perez-Perez, Aieska De Souza et al. · Microbiome Open access Dec 2013 463
40 γ-Secretase Gene Mutations in Familial Acne Inversa Baoxi Wang, Wei Yang, Wen Wen et al. · Science 7 Oct 2010 463
41 Diagnostic Criteria of Ulcerative Pyoderma Gangrenosum Emanual Michael Maverakis, Chelsea Ma, Kanade Shinkai et al. · JAMA Dermatology Open access 14 Feb 2018 453
42 Increased US Emergency Department Visits for Skin and Soft Tissue Infections, and Changes in Antibiotic Choices, During the Emergence of Community-Associated Methicillin-Resistant Staphylococcus aureus Daniel J. Pallin, Daniel J. Egan, Andrea J. Pelletier et al. · Annals of Emergency Medicine 30 Jan 2008 448
43 Expression of the IL-23/Th17 pathway in lesions of hidradenitis suppurativa Christoph Schlapbach, Tanja Hänni, Nikhil Yawalkar et al. · Journal of the American Academy of Dermatology 19 Jun 2011 428
44 Infliximab therapy for patients with moderate to severe hidradenitis suppurativa: A randomized, double-blind, placebo-controlled crossover trial Annika Grant, Tayler Gonzalez, Michael O. Montgomery et al. · Journal of the American Academy of Dermatology 15 Jan 2010 420
45 Adalimumab for the Treatment of Moderate to Severe Hidradenitis Suppurativa Alexa B. Kimball, Francisco A. Kerdel, David R. Adams et al. · Annals of Internal Medicine 18 Dec 2012 416
46 Circumferential mucosectomy (stapled haemorrhoidectomy) versus conventional haemorrhoidectomy: randomised controlled trial Mark Rowsell, Mariana de Carlo Bello, DM Hemingway · The Lancet Mar 2000 415
47 Homozygous mutations in LPIN2 are responsible for the syndrome of chronic recurrent multifocal osteomyelitis and congenital dyserythropoietic anaemia (Majeed syndrome) Polly J. Ferguson, S Chen, M K Tayeh et al. · Journal of Medical Genetics Open access Jul 2005 412
48 Incidence of Hidradenitis Suppurativa and Associated Factors: A Population-Based Study of Olmsted County, Minnesota Benjamin G. Vazquez, Ali Alikhan, Amy L. Weaver et al. · Journal of Investigative Dermatology Open access 30 Aug 2012 411
49 Etiology and Management of Pyoderma Gangrenosum Iris Z. Ahronowitz, JOANNA LEE HARP, Kanade Shinkai · American Journal of Clinical Dermatology 24 Feb 2012 409
50 Treatment recommendations for pyoderma gangrenosum: An evidence-based review of the literature based on more than 350 patients Jörg Reichrath, Guido Bens, Anette Bonowitz et al. · Journal of the American Academy of Dermatology 14 Jul 2005 407

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for a field when OpenAlex files it under one of the field's topics; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.